COMMD3 Activators
COMMD3 Activators can exert their influence through a variety of biochemical mechanisms, primarily by modulating the activity of different kinases and phosphodiesterases. Some activators target adenylate cyclase, leading to an increase in intracellular cAMP, which in turn activates protein kinase A. Activated PKA has a wide range of substrates that it can phosphorylate, and this phosphorylation cascade can extend to include COMMD3, enhancing its activity. Other activators work by inhibiting phosphodiesterases that degrade cAMP or cGMP, leading to the accumulation of these cyclic nucleotides within the cell. The resultant elevated levels of cAMP or cGMP can further stimulate their respective protein kinases. These kinases, by phosphorylating various proteins, may also target COMMD3, thus amplifying its functional role.
Additionally, some activators exert their influence on COMMD3 by affecting calcium signaling or the cytoskeleton. For instance, certain activators increase the intracellular concentration of calcium, which activates calcium-dependent protein kinases capable of modifying COMMD3's function. In a different approach, activators that interfere with cytoskeletal dynamics can indirectly modify the signaling pathways that control the activity of COMMD3. This includes the inhibition of kinases like the Rho-associated protein kinase, which has downstream effects that potentially include the activation of COMMD3. Other activators may inhibit enzymes such as glycogen synthase kinase or histone deacetylases, resulting in altered gene expression or cellular signaling processes that indirectly promote the activity of COMMD3.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
An adenylate cyclase activator that increases intracellular cAMP levels. Elevated cAMP enhances protein kinase A (PKA) activity, which can phosphorylate substrates leading to the functional activation of COMMD3. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
A non-selective phosphodiesterase inhibitor that prevents cAMP degradation, thus potentiating cAMP-dependent pathways which may include the activation of PKA and subsequent phosphorylation of proteins, like COMMD3, involved in the pathway. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
A phorbol ester that activates protein kinase C (PKC). PKC signaling can phosphorylate various proteins, potentially including COMMD3, thereby enhancing its activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
A calcium ionophore that increases intracellular calcium concentration. The rise in calcium levels can activate calcium-dependent protein kinases, which may lead to the phosphorylation and activation of COMMD3. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
A selective inhibitor of cGMP-specific phosphodiesterase 5 (PDE5). By preventing cGMP breakdown, it can enhance protein kinase G (PKG) activity, which may in turn phosphorylate and activate COMMD3. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
A selective inhibitor of phosphodiesterase 4 (PDE4), leading to an increase in cAMP levels. The accumulated cAMP can activate PKA that may phosphorylate and activate COMMD3. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
A selective inhibitor of the Rho-associated protein kinase (ROCK). Inhibition of ROCK can lead to changes in cytoskeletal dynamics that could indirectly influence the activation of COMMD3 through related signaling pathways. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
A myosin light chain kinase inhibitor that affects cytoskeletal dynamics. Such changes in the cytoskeleton could influence signaling pathways that regulate the activity of proteins including COMMD3. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
An inhibitor of glycogen synthase kinase 3 (GSK-3). Inhibition of GSK-3 can activate the Wnt signaling pathway, which might indirectly result in the activation of COMMD3 through downstream effects. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
A compound known to inhibit NF-κB activation. The suppression of NF-κB can lead to compensatory cellular responses that may include the activation of alternative signaling pathways involving COMMD3. | ||||||